Reference number : 276-2017-2018-Q4-00202, amendment number : , agreement type : C, recipient legal name : Precision BioLogic Incorporated|Precision BioLogic Incorporated, recipient country : CA, recipient province : NS, recipient city : Dartmouth|Dartmouth, recipient postal code : B3B 0A9, program name english : Business Development Program, program name french : Programme de développement des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 211486, agreement title french : 211486, agreement number : 211486, agreement value : 500000.0, agreement start date : 2018-03-21, agreement end date : 2019-09-30, description english : Commercialization of a chromogenic Activity Assay to the Management of Hemophilia A, description french : Commercialiser un dosage chromogène pour la gestion de l'hémophilie A, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution., additional information french : Le type d'aide est Contribution à remboursement inconditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique